TO KNOW THE AMOUNT OF CANINE MOVEMENT AFTER LOCAL INJECTION OF INJECTIBLE PLATELET RICH FIBRIN.
- Conditions
- Health Condition 1: 3- AdministrationHealth Condition 2: K03- Other diseases of hard tissues ofteeth
- Registration Number
- CTRI/2024/04/065362
- Lead Sponsor
- Dr Nikita Navgire
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Class I bimax cases requiring first premolar extraction with absolute anchorage.
2.Class II crowding cases requiring first premolar extraction with absolute anchorage.
3.Class II division 1, camouflage cases requiring first premolar extraction with absolute anchorage.
1.Patients with bone metabolic and blood disorders.
2.Patients with mental disability.
3.Patients with congenital deformity of Oro-Facial structures.
4.Chronic ulcers in oral cavity.
5.Chronic Periodontitis.
6.Facial asymmetry
7.Patients with systemic or chronic debilitating disease that could interfere with bone remodeling.
8.Patients on long-term systemic corticosteroids, calcium channel blockers, antibiotics, bisphosphonates. Or any other medications that could adversely affect the development of the jaws and teeth and subsequent tooth movement.
9.Patients with craniofacial deformities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acceleration of orthodontic tooth movement and thus reduction in treatment duration.Timepoint: T0- at baseline <br/ ><br>T1- at 30 days <br/ ><br>T2- at 60 days <br/ ><br>T3- at 90 days <br/ ><br>T4- at 120 days <br/ ><br>T5- at 150 days <br/ ><br>T6- at 180 days.
- Secondary Outcome Measures
Name Time Method ACHIEVING SPACE CLOSURETimepoint: T0- at baseline <br/ ><br>T1- at 30 days <br/ ><br>T2- at 60 days <br/ ><br>T3- at 90 days <br/ ><br>T4- at 120 days <br/ ><br>T5- at 150 days <br/ ><br>T6- at 180 days.